Today: 2 June 2026
Browse Category

Pharmaceuticals 22 July 2025

Revolutionary Medical Breakthroughs of July 2025: Life-Changing Drugs, Diagnostic Wonders & Public Health Milestones

Revolutionary Medical Breakthroughs of July 2025: Life-Changing Drugs, Diagnostic Wonders & Public Health Milestones

On July 2, 2025, the FDA granted accelerated approval to linvoseltamab for relapsed/refractory multiple myeloma and approved sunvozertinib as the first targeted oral therapy for advanced NSCLC with EGFR exon 20 insertion mutations. The FDA also cleared denosumab biosimilars for osteoporosis, and Senegal was declared free of trachoma by the WHO.
22 July 2025
·
1 … 39 40 41

Latest articles

T1 Energy Shares Reach Record; What Comes Next Is Uncertain

T1 Energy Shares Reach Record; What Comes Next Is Uncertain

2 June 2026
T1 Energy Inc. surged 12.5% to a record $12.18 as investors bet on its solar modules for AI data centers, outpacing peers after strong Q1 results and bullish options activity; the rally lifted shares above recent analyst targets, but risks remain with single-customer reliance, pending $400M+ factory financing, and ongoing debate over tax-credit eligibility.
Redwire’s Space Surge Pauses as Jefferies Lowers Rating

Redwire’s Space Surge Pauses as Jefferies Lowers Rating

2 June 2026
Redwire shares rose 0.7% after Jefferies cut its rating to “Hold,” warning the stock’s 223% year-to-date rally outpaced fundamentals, with adjusted EBITDA expected to stay negative in 2026; as SpaceX’s record IPO looms, Redwire’s backlog hit a record $498.1 million, but risks include unconverted orders and a recent share sale that raised $63.5 million while increasing share count.
BlackBerry Stock Hits 52-Week High as Traders Watch BB

BlackBerry Stock Hits 52-Week High as Traders Watch BB

2 June 2026
BlackBerry shares surged 4.2% to a 52-week high of $10.26 as investors piled in on QNX robotics-software momentum, FedRAMP security recertification, a renewed buyback, and heavy investor-conference attention, but with a price-to-earnings ratio of 114, the stock’s rapid $2.1 billion market cap jump faces a critical test at the June 25 earnings report.
Grab Stock Barely Moves. Its Bank Bet Is the Real Test Now

Grab Stock Barely Moves. Its Bank Bet Is the Real Test Now

2 June 2026
Grab Holdings slipped 0.3% to $3.60 as investors weighed its 24% Q1 revenue jump and $120 million profit against unchanged full-year guidance and ongoing concerns about costs and risks tied to its Superbank consolidation, digital banking exposure, and consumer spending pressures.
Bitmine Faces Market Jolt as $11.6B Ether Position Hits Rough Patch

Bitmine Faces Market Jolt as $11.6B Ether Position Hits Rough Patch

2 June 2026
Bitmine shares plunged 6.5% to $17.62 after the company revealed its ether holdings hit 5.42 million tokens, exposing investors to a $502 million drop in ETH value as the token slid 4%, underscoring the stock’s sensitivity to crypto price swings and Bitmine’s shift from bitcoin mining to massive ether bets.
Go toTop